Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 3/20 | 0.60 |
| ▸ | TP53 | P04637 | 3/20 | 0.60 |
| ▸ | CASP3 | P42574 | 2/20 | 0.57 |
| ▸ | TLR2 | O60603 | 2/20 | 0.54 |
| ▸ | MDM2 | Q00987 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30353997 | 1.00 | MDM4 (0.60) | MDM4TP53CASP3TLR2MDM2 | |
| SCHEMBL29378420 | 1.00 | MDM4 (0.60) | MDM4TP53CASP3TLR2MDM2 | |
| SCHEMBL30191581 | 1.00 | MDM4 (0.60) | MDM4TP53CASP3TLR2MDM2 | |
| SCHEMBL119339 | 1.00 | MDM4 (0.60) | MDM4TP53CASP3TLR2MDM2 | |
| SCHEMBL178787 | 1.00 | MDM4 (0.60) | MDM4TP53CASP3TLR2MDM2 | |
| SCHEMBL31675022 | 1.00 | MDM4 (0.60) | MDM4TP53CASP3TLR2MDM2 | |
| SCHEMBL29792126 | 1.00 | MDM4 (0.60) | MDM4TP53CASP3TLR2MDM2 | |
| SCHEMBL118051 | 1.00 | MDM4 (0.60) | MDM4TP53CASP3TLR2MDM2 | |
| Water SCHEMBL21809391 | 0.99 | MDM4 (0.59) | MDM4TP53CASP3TLR2MDM2 | |
| SCHEMBL22636280 | 0.93 | MDM4 (0.59) | MDM4TP53CASP3TLR2MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117924431-A | Natural cyclopeptide zelkovamycins simplified substance and preparation method and application thereof | 北流市中医医院 | 2024-04-26 | — | — | CN | claimed |
| EP-4732286-A2 | COMPOSITIONS AND METHODS FOR ENCRYPTING, STORING, AND DECRYPTING INFORMATION IN OLIGOMERS | Board of Regents, The University of Texas System (US) | 2026-04-29 | — | — | EP | disclosed |
| WO-2025058677-A2 | COMPOSITIONS AND METHODS FOR ENCRYPTING, STORING, AND DECRYPTING INFORMATION IN OLIGOMERS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-03-20 | — | — | WO | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240269227-A1 | CALCIUM-SENSING RECEPTOR AGONIST COMPOSITION AND APPLICATION THEREOF | BEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD. (CN) | 2024-08-15 | — | — | US | disclosed |
| CN-118256591-A | Cyclic peptide compound having high membrane permeability and library comprising same | 中外制药株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-118184532-A | Amino acid having functional group capable of forming intramolecular hydrogen bond, peptide compound containing the amino acid, and process for producing the same | 中外制药株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-117924431-A | Natural cyclopeptide zelkovamycins simplified substance and preparation method and application thereof | 北流市中医医院 | 2024-04-26 | — | — | CN | disclosed |
| EP-4353248-A1 | CALCIUM-SENSING RECEPTOR AGONIST COMPOSITION AND APPLICATION THEREOF | Beijing Tuo Jie Biopharmaceutical Co. Ltd. (CN) | 2024-04-17 | — | — | EP | disclosed |
| CN-113454058-B | Amino acid having functional group capable of forming intramolecular hydrogen bond, peptide compound containing the amino acid, and process for producing the same | 中外制药株式会社 | 2024-03-22 | — | — | CN | disclosed |
| CN-117295510-A | Composition of calcium sensitive receptor agonist and application thereof | 北京拓界生物医药科技有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20230096766-A1 | AMINO ACID HAVING FUNCTIONAL GROUP CAPABLE OF INTERMOLECULAR HYDROGEN BONDING, PEPTIDE COMPOUND CONTAINING SAME AND METHOD FOR PRODUCTION THEREOF | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-03-30 | — | — | US | disclosed |
| US-20230041996-A1 | CALCIUM-SENSING RECEPTOR AGONIST COMPOUND AND APPLICATION THEREOF | BEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD. (CN) | 2023-02-09 | — | — | US | disclosed |
| WO-2022257958-A1 | CALCIUM-SENSING RECEPTOR AGONIST COMPOSITION AND APPLICATION THEREOF | 北京拓界生物医药科技有限公司 | 2022-12-15 | — | — | WO | disclosed |
| WO-2022257940-A1 | HYDROCHLORIDE SALT OF CALCIUM-SENSING RECEPTOR AGONIST COMPOUND AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 北京拓界生物医药科技有限公司 | 2022-12-15 | — | — | WO | disclosed |
| EP-4091623-A1 | CALCIUM-SENSING RECEPTOR AGONIST COMPOUND AND APPLICATION THEREOF | Beijing Tuo Jie Biopharmaceutical Co. Ltd. (CN) | 2022-11-23 | — | — | EP | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240269227-A1 | CALCIUM-SENSING RECEPTOR AGONIST COMPOSITION AND APPLICATION THEREOF | CASR, PTH1R, CALCR | MDM4 4062/4885TP53 2077/4885CASP3 3038/4885 |
| US-20230096766-A1 | AMINO ACID HAVING FUNCTIONAL GROUP CAPABLE OF INTERMOLECULAR HYDROGEN BONDING, PEPTIDE COMPOUND CONTAINING SAME AND METHOD FOR PRODUCTION THEREOF | VIP, DNPEP, HM13 | MDM4 3098/4885TP53 3050/4885CASP3 2217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.